These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12369170)

  • 1. [Hyperforin in St. John's wort--drug, extraction and preparations].
    Lang F; Biber A; Erdelmeier C
    Pharm Unserer Zeit; 2002; 31(5):512-4. PubMed ID: 12369170
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
    Rückert U; Likussar W; Michelitsch A
    Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
    Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M
    J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
    [No Abstract]   [Full Text] [Related]  

  • 8. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
    Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
    J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD; Naït-Si Y
    Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
    Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
    Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort.
    Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes.
    Hokkanen J; Tolonen A; Mattila S; Turpeinen M
    Eur J Pharm Sci; 2011 Feb; 42(3):273-84. PubMed ID: 21168483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
    de los Reyes GC; Koda RT
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):959-65. PubMed ID: 11600308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
    Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
    J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.